SUPPLY OF CHLORAMPHENICOL EYE DROPS 0.5% UNDER THE MINOR AILMENT SERVICE

Similar documents
SUPPLY OF CHLORAMPHENICOL EYE DROPS 0.5% UNDER THE MINOR AILMENT SERVICE

Author of PGD: Adrian MacKenzie, Lead Pharmacist, Community Pharmacy.

Please call the Pharmacy Medicines Unit on or for a copy.

THIS PATIENT GROUP DIRECTION HAS BEEN APPROVED on behalf of NHS Fife by:

appropriate healthcare professionals employed at my pharmacy. I understand that I am

Minims Chloramphenicol

November 2017 Review Nov Signatures of those developing the Patient Group Direction Job Title Name Signature Date Doctor Stephanie Dundas

Submission for Reclassification

The active component of CHLOROMYCETIN eye ointment is chloramphenicol.

Package leaflet: Information for the user. GENTAMICIN VISION 3 mg/ml eye drops, solution Gentamicin

PRODUCT INFORMATION CHLORSIG

Job Title Name Signature Date

PRESCRIBING INFORMATION

PACKAGE LEAFLET: INFORMATION FOR THE USER. GENTAMICIN VISION 3 mg/g eye ointment Gentamicin

Delayed Prescribing for Minor Infections Resource Pack for Prescribers

Package leaflet: Information for the user. HYDROCORTISON CUM CHLORAMPHENICOL 5 mg/g + 2 mg/g eye ointment hydrocortisone acetate, chloramphenicol

New PGD. This direction was authorised on: Oct The direction will be reviewed by: Oct Author of PGD: Anne Duguid, Antimicrobial Pharmacist

New Zealand Consumer Medicine Information

LABELLING AND PACKAGE LEAFLET

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

PGD previously approved: October This direction was authorised on: October The direction will be reviewed by: October 2019

SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

The Implications of the Shift from Prescribing to OTC use of Chronic Medications

notification of entry onto webpage Document Links

Antimicrobial Update Stewardship in Primary Care. Clare Colligan Antimicrobial Pharmacist NHS Forth Valley

Prescribing Guidelines for Outpatient Antimicrobials in Otherwise Healthy Children

Patient Group Direction for METRONIDAZOLE (Version 03) Valid From 1 June May 2020

Developed By Name Signature Date

Summary of Product Characteristics

SUMMARY OF PRODUCT CHARACTERISTICS

Collagen cross-linking after-care instructions

Summary of Product Characteristics

Summary of Product Characteristics

SUMMARY OF PRODUCT CHARACTERISTICS. Bottle of powder: Active substance: ceftiofur sodium mg equivalent to ceftiofur...

B. PACKAGE LEAFLET 1

SUMMARY OF PRODUCT CHARACTERISTICS. Procaine penicillin Dihydrostreptomycin Sulfate

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

EXCEDE Sterile Suspension

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

PACKAGE LEAFLET: INFORMATION FOR THE USER. Amikacin 250 mg/ml Injection

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1/18

B. PACKAGE LEAFLET 1

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Package leaflet: Information for the patient. FLUCLOXACILLIN 250MG/5ML ORAL SOLUTION Flucloxacillin

SUMMARY OF PRODUCT CHARACTERISTICS 1.B.1 SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS. Pentoject, Pentobarbitone Sodium 200 mg/ml Solution for Injection

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

PATIENT INFORMATION LEAFLET DYNA CEFPODOXIME 100 mg / DYNA CEFPODOXIME SUSPENSION:

PATIENT INFORMATION LEAFLET GENTAMICIN 10MG/ML SOLUTION FOR INJECTION OR INFUSION. and GENTAMICIN 40MG/ML SOLUTION FOR INJECTION OR INFUSION

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX III LABELLING AND PACKAGE LEAFLET

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

MARBOCYL 10% SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS. Cephacare flavour 50 mg tablets for cats and dogs. Excipients: For a full list of excipients, see section 6.1.

Package leaflet: Information for the user

CLINICAL PROTOCOL FOR COMMUNITY ACQUIRED PNEUMONIA. SCOPE: Western Australia. CORB score equal or above 1. All criteria must be met:

Withdrawal period: 93 days Milk: Not authorised for use in animals producing milk for human consumption.

Enhancing the quality of antimicrobial prescribing through education in NHSScotland

A first-line treatment for ear infections in children with ear tubes*

Irish Medicines Board

Gentamicin or Tobramycin for Peritonitis in Peritoneal Dialysis

Acute Pyelonephritis POAC Guideline

SUMMARY OF PRODUCT CHARACTERISTICS

Summary of Product Characteristics

For the treatment of infections caused by a wide range of Gram-positive and Gramnegative pathogenic bacteria including:

PROFESSIONAL PRACTICE STANDARD

Health Products Regulatory Authority

SUMMARY OF PRODUCT CHARACTERISTICS

Amoxicillin 250mg Hard Capsules Amoxicillin 500mg Hard Capsules

PART IB1 SUMMARY OF PRODUCT CHARACTERISTICS OCTACILLIN

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Prescription Label. Patient Name: Species: Drug Name & Strength: Directions (amount to give how often & for how long):

Indicated for the treatment of pruritus associated with allergic dermatitis and the clinical manifestations of atopic dermatitis in dogs.

Therios 300 mg and 750 mg Palatable Tablets for Dogs

The Community Pharmacy and Veterinary Medicines. The Opportunities

[Version 7.2, 12/2008] ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

[Version 8.1,01/2017] ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

THE NEW ZEALAND MEDICAL JOURNAL

Metacam 1.5 mg/ml oral suspension for dogs

Other ingredients are sodium chloride and purified water.

SUMMARY OF PRODUCT CHARACTERISTICS. NUFLOR 300 mg/ml solution for injection for cattle and sheep

GENTAMICIN SULFATE- gentamicin sulfate solution/ drops Pacific Pharma, Inc GENTAMICIN SULFATE ophthalmic s olution, USP 0.

PACKAGE LEAFLET: INFORMATION FOR THE USER. AMOXICILLIN 250mg and 500mg CAPSULES BP Amoxicillin (as amoxicillin trihydrate)

SUMMARY OF PRODUCT CHARACTERISTICS. Equest Oral Gel, 18,92 mg/g, Oral Gel for Horses and Ponies

Author s: Clinical Standards Group and Effectiveness Sub-Board

Error! Reference source not found. I. SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS FOR CATS

= 0.5 mg. In vitro toxin neutralisation test based on haemolysis of sheep erythrocytes. For a full list of excipients, see section 6.1.

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Summary of Product Characteristics

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Antibiotics. Information for patients and carers Pharmacy Department. Patient information leaflet

Simplicef is Used to Treat Animals with Skin Infections

Irish Medicines Board

PACKAGE LEAFLET Page 1 of 6

Transcription:

NHS LANARKSHIRE PATIENT GROUP DIRECTION SUPPLY OF CHLORAMPHENICOL EYE DROPS 0.5% UNDER THE MINOR AILMENT SERVICE Effective date : 1 July 2008 Review date : 30 June 2010 P1

Name of Medicine : Chloramphenicol Eye Drops 0.5% Legal Classification : PGD Ref No : Replacing PGD Ref No : POM NHS LANARKSHIRE EMAS CHLORAMPHENICOL JULY 2008 NHS LANARKSHIRE EMAS CHLORAMPHENICOL JULY 2006 Effective Date : 1 July 2008 Review Date : 30 June 2010 Professional Group authorised to use PGD : Community Pharmacist registered as a member of the Royal Pharmaceutical Society. The pharmacist should have an uptodate knowledge of the most recent RPSGB Practice guidance for the use of OTC chloramphenicol eye drops, recognizing that this PGD allows treatment of children aged 1 yr and over. PGD /reviewed* by : (*delete as appropriate) Doctor Pharmacist NHS Board Name Signature Date P. McMenemy A Thorburn Lanarkshire P McMenemy* A Thorburn* 24/6/08 25/6/08 Approved for use by Primary care Drugs & Therapeutics Committee : 19/6/08 Approved on behalf of NHS Board Name Signature Date Dr A Graham A Graham* 24/6/08 Medical Director Chief Pharmacist, G Lindsay G Lindsay* 24/6/08 Primary Care * Original Signatures on File with G Lindsay To apply to use this PGD, please sign and return page 5 P2

Description of Treatment Name of medicine : POM/P/GSL : Pharmaceutical Form : Chloramphenicol POM Strength : 0.5% Dosage : Total Dosage: Route of Administration : Frequency of Administration : Duration of Treatment : Total Treatment Quantity : Clinical Situation for use of this PGD Inclusion Criteria Eye Drops Adults and children 1 years and over - Apply one (1) drop at least every two (2) hours then reduce frequency to four hourly after 48 hours as infection is controlled and continue for 48 hours after healing. Sleep need not be interrupted in order to administer the drops. For a total of five (5) days Ocular Adults and children 1 years and over - Apply one (1) drop at least every two (2) hours then reduce frequency as infection is controlled and continue for 48 hours after healing For a total of five (5) days 10ml Conjunctivitis will give the sensation of a gritty or itchy eye or eyes, with possibly a purulent discharge or crusting of the eyelid margins. It will only have been present for a few days and is not associated with any change in vision. The affected eye(s) will often look slightly red/injected, but this is not usually very marked. Pain is not a feature of simple conjunctivitis. Presentation in Community Pharmacy with a need for treatment of symptoms of bacterial conjunctivitis, and registered for the Minor Ailment Service (MAS). Exclusion Criteria Action if patient is excluded from treatment under this PGD This PGD authorises supply of the POM pack of Chloramphenicol including its use for patients of 1 year of age or over. Patient not participating in MAS. Children under 1 year. Patient or family history of blood dyscrasias or aplastic anaemia Concurrent administration of medicines which may depress bone marrow Recurrence of symptoms within last three months Pregnancy, Breast feeding Known hypersensitivity to chloramphenicol, benzalkonium chloride or disodium edetate. Refer to GP P3

Referral Criteria Urgent referral : - if painful, rather than itchy or gritty - if reduced visual acuity - if eye looks cloudy - if pus level visible in anterior chamber - if any history of trauma to eye, or grinding, immediately prior to onset of symptoms - if possibility of foreign body on/in eye - if history of welding without eye protection immediately prior to onset of symptoms - if no improvement within 48 hours of starting the drops - any signs of periorbital cellulitis - any signs of photophobia Adverse Effects Follow-up treatment Written/Verbal Advice to be given to patient Record required of Supply/Administration Routine referral : - pregnancy - breast feeding - present for more than 2 weeks despite self care measures with no urgent referral symptoms. Occasional : Transient stinging on instillation. Rare : Allergic reaction (persistent burning, swelling of lids) None Patient Information Leaflets. Contact lenses should be removed during period of treatment. Continue for at least 48 hours after the eye appears normal. Store in a fridge (between 2-8º), and keep cap tightly closed between applications. Discard 28 days after opening. Following to be noted in the computerised patient information records and on the CP 2 form : Dose, frequency and the quantity supplied Date of supply to patient In the event of a Suspected Adverse Drug Reaction complete a yellow card and submit to CSM Scotland CARDS FREEPOST NAT 3271 EDINBURGH EH16 4BR A yellow card can be found at the rear of the BNF. Also record findings, advice and actions in person s record. P4

PATIENT GROUP DIRECTION NHS LANARKSHIRE Agreement by Practitioner SUPPLY OF CHLORAMPHENICOL EYE DROPS 0.5 by COMMUNITY PHARMACISTS I have read and fully understand the Patient Group Direction for the supply of Chloramphenicol Eye Drops 0.5% and agree to provide this medicine only in accordance with this PGD. Name of Pharmacist RPSGB Registration Number Normal Pharmacy Location Pharmacy Contractor Code Signature : Date : Note : A copy of this agreement must be signed by each pharmacist who wishes to be authorised to use the PGD for the supply of Chloramphenicol Eye Drops under MAS. Each authorised pharmacist should ensure they have an individual copy of the clinical content of this PGD and a photocopy of the page showing their signature The pharmacist is not authorised to apply the PGD until they have signed and returned this form to: Please sign and return this page to: Anne Buchanan, Secretary to Chief Pharmacist, Primary Care Strathclyde hospital, MOTHERWELL ML1 3BW Fax 01698 245091 P5